The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | BMJ, The | 2021 | 666 |
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Systematic Reviews | 2021 | 513 |
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 461 |
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | PLoS Medicine | 2021 | 286 |
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement | Journal of Clinical Epidemiology | 2021 | 279 |
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 | New England Journal of Medicine | 2021 | 227 |
PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews | Systematic Reviews | 2021 | 218 |
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | New England Journal of Medicine | 2021 | 203 |
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Journal of Clinical Epidemiology | 2021 | 201 |
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis | Clinical Microbiology and Infection | 2021 | 164 |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Blood Advances | 2021 | 161 |
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis | JAMA - Journal of the American Medical Association | 2021 | 110 |
Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews | Journal of Clinical Epidemiology | 2021 | 109 |
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer | Blood Advances | 2021 | 96 |
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature Communications | 2021 | 83 |
Global prevalence of mental health issues among the general population during the coronavirus disease-2019 pandemic: a systematic review and meta-analysis | Scientific Reports | 2021 | 83 |
140 Past and Future Changes in Scientific Publishing | Journal of Animal Science | 2021 | 78 |
The Impact of Infectious Disease-Related Public Health Emergencies on Suicide, Suicidal Behavior, and Suicidal Thoughts | Crisis | 2021 | 71 |
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial | BMJ, The | 2021 | 54 |
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. | JAMA Oncology | 2021 | 51 |
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease | Kidney International | 2021 | 51 |
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report | Chest | 2021 | 48 |
The effect of COVID-19 pandemic on the mental health of Canadian critical care nurses providing patient care during the early phase pandemic: A mixed method study | Intensive and Critical Care Nursing | 2021 | 46 |
Venous thromboembolism | Lancet, The | 2021 | 40 |